The risk of incident atherosclerotic cardiovascular disease (ASCVD) among patients with end-stage renal disease (ESRD) is between 5 and 20 times that seen in the general population. Many of the traditional Framingham risk factors, however, do not have the same risk profiles in ESRD as in the general population. Large studies of lipids and mortality in ESRD have found an inverse relationship to that seen in the general population, such that higher mortality is associated with lower total cholesterol (TC), low density lipoprotein cholesterol (LDL-C) and triglycerides (TG). The etiology of this inverse relationship is poorly understood, but in part results from the high degree of comorbid illness and malnutrition seen in the dialysis population. Overall mortality is associated with low body mass index (BMI), low albumin and low creatinine in ESRD. The relationship between lipids and incident ASCVD in ESRD may also be clouded by these same factors. Few prospective studies investigating the association between lipids [including TC,LDL-C, TG, high-density lipoprotein cholesterol (HDL-C), apolipoprotein-A1 (apo-A1) and apolipoprotein-B (apo-B)] and clinical ASCVD events in ESRD have been performed. Most of these studies recruited prevalent ESRD patients and adjusted for limited confounding variables. The CHOICE Study is comprised of 876 incident ESRD patients with a wide range of data on confounding variables in addition to serum banked within 3 months of enrollment into the study. This grant seeks funding for a lipid panel including TC, HDL-C, apo-A1, LDL-C, apo-B, and TG for 876 CHOICE participants to test the hypothesis that: Low HDL-C and apo-A1 levels, and high TC, LDL-C, apo-B and TG levels will predict incident ASCVD events, after adjustment for comorbidity, BMI, dialysis dose, creatinine and albumin. The rationale for this hypothesis is that if adjustment is made for these and other confounding factors, an underlying positive relationship between lipids and ASCVD may be observable.
| AIDS-defining Cancer Project Working Group of IeDEA, COHERE in EuroCoord (2018) Non-Hodgkin lymphoma risk in adults living with HIV across five continents. AIDS 32:2777-2786 |
| Juraschek, Stephen P; Miller 3rd, Edgar R; Appel, Lawrence J (2018) Orthostatic Hypotension and Symptoms in the AASK Trial. Am J Hypertens 31:665-671 |
| Elion, Richard A; Althoff, Keri N; Zhang, Jinbing et al. (2018) Recent Abacavir Use Increases Risk of Type 1 and Type 2 Myocardial Infarctions Among Adults With HIV. J Acquir Immune Defic Syndr 78:62-72 |
| Al-Sofiani, Mohammed E; Yanek, Lisa R; Faraday, Nauder et al. (2018) Diabetes and Platelet Response to Low-Dose Aspirin. J Clin Endocrinol Metab 103:4599-4608 |
| Grover, Surbhi; Desir, Fidel; Jing, Yuezhou et al. (2018) Reduced Cancer Survival Among Adults With HIV and AIDS-Defining Illnesses Despite No Difference in Cancer Stage at Diagnosis. J Acquir Immune Defic Syndr 79:421-429 |
| Grams, Morgan E; Sang, Yingying; Ballew, Shoshana H et al. (2018) Predicting timing of clinical outcomes in patients with chronic kidney disease and severely decreased glomerular filtration rate. Kidney Int 93:1442-1451 |
| Yanik, Elizabeth L; Hernández-Ramírez, Raúl U; Qin, Li et al. (2018) Brief Report: Cutaneous Melanoma Risk Among People With HIV in the United States and Canada. J Acquir Immune Defic Syndr 78:499-504 |
| Aboud, Katherine S; Barquero, Laura A; Cutting, Laurie E (2018) Prefrontal mediation of the reading network predicts intervention response in dyslexia. Cortex 101:96-106 |
| Kattan, Meyer; Bacharier, Leonard B; O'Connor, George T et al. (2018) Spirometry and Impulse Oscillometry in Preschool Children: Acceptability and Relationship to Maternal Smoking in Pregnancy. J Allergy Clin Immunol Pract 6:1596-1603.e6 |
| Altekruse, Sean F; Shiels, Meredith S; Modur, Sharada P et al. (2018) Cancer burden attributable to cigarette smoking among HIV-infected people in North America. AIDS 32:513-521 |
Showing the most recent 10 out of 1014 publications
